USD 1.3 billion
Global Fibromyalgia Treatment Market Size, Share, Growth Analysis, By Drug class(Antidepressants, Antiepileptic), By Distribution Channels(Hospital pharmacies, Retail pharmacies) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2821 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
64 |
Figures:
67
Global Fibromyalgia Treatment Market Insights
Global Fibromyalgia Treatment Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.39 billion in 2023 to USD 2.39 billion by 2031, growing at a CAGR of 7.00% in the forecast period (2024-2031).
Fibromyalgia is a chronic pain disorder characterized by widespread pain, fatigue, and other symptoms including sleep disturbance, mood issues, and mood swings. The condition is estimated to affect about 2% of the worldwide adult population, with a higher prevalence in women compared to men. Despite a lot of research, there is currently no cure for fibromyalgia.
However, treatments are available to help manage symptoms and improve the overall quality of life of individuals affected by this condition. Treatment strategies often involve medications, lifestyle changes, and non-treatment of combination chemotherapy. The goal is to relieve pain, improve sleep, manage psychological challenges, and improve overall well-being. The multidisciplinary nature of fibromyalgia treatment highlights the complexity of managing its symptoms, and an individualized approach is often adopted to prepare dependent interventions on individual needs and responses.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Antiepileptic
Fastest Growth
Antiepileptic
Growth Rate
7.00% CAGR
Global Fibromyalgia Treatment Market ($ Bn)
Country Share for North america Region (%)
Global Fibromyalgia Treatment Market By Drug Class ($ Bn)
Global Fibromyalgia Treatment Market By Drug Class (%)
To get more reports on the above market click here to Buy The Report
Global Fibromyalgia Treatment Market Segmental Analysis
On the basis of drug class, the market is categorized into antidepressants, antiepileptic, muscle relaxants, and others (incl. pipeline products). Based on the segmentation of distribution channels, the fibromyalgia treatment market includes hospital pharmacies, retail pharmacies, and online pharmacies. On the basis of region, the market is categorized into North America, Latin America, Europe, Asia Pacific, Middle East & Africa.
Analysis by Distribution Channels
Availability of fibromyalgia drugs through hospital pharmacies is expected to be a major driver for the growth of this segment during the forecast period. The convenience and wide availability in retail hospitals also contributes to its convenience that patients can buy their prescriptions according to fibromyalgia treatment, often without the need for hospitalization and imposes a large market share on retail pharmacies. Patients often want the convenience of being able to source their medicines from retail outlets, which increases the potential of this segment.
The online pharmacy segment plays an important role in the fibromyalgia treatment market by providing a convenient and easy way for patients to access their prescriptions. This segment has gained importance as part of the evolving healthcare sector, which provides a digital platform for individuals dealing with fibromyalgia to buy their vital treatments from the comfort of their home and support the market by facilitating fibromyalgia medicines, dispensing and ensuring prescriptions will be provided in due course.
Analysis by Drug Class
The anti-epileptic segment, driven by Pfizer Lyrica's massive fundraising, established itself as a major force in the treatment of fibromyalgia and emerged as the market leader. Classified as an anti-epileptic drug, Lyrica gained widespread adoption in the treatment of fibromyalgia in populations.
The relaxation component had the second highest share. Though anticipated to show a slower growth rate, the positioning in this segment is influenced by the potential product entry in the market. Despite the anticipated decline, nerve agents dryness is gaining increasing acceptance in developing regions such as Latin America, the Middle East and Africa. This geographical coverage highlights global muscle relaxant drugs used in the treatment of fibromyalgia, highlights market dynamics, and the importance of local priorities in fibromyalgia the formation of all states of the chemicals.
Global Fibromyalgia Treatment Market By Drug Class, 2022 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Fibromyalgia Treatment Market Regional Insights
North America in the fibromyalgia treatment market posted the highest revenue, at USD 1,253.5 million, and is expected to maintain significant market growth throughout the forecast period. This growth is driven by the high volumes seen in the region which may also lead to widespread and more advanced approved products that can be used to manage the disease.
Asia-Pacific is expected to show consistent growth throughout the forecast period, with several factors contributing to the evolving fibromyalgia treatment scenario in the region and increasing patients with fibromyalgia, healthcare expenditure simultaneous increases and improved health care facilities will provide a better environment.
Global Fibromyalgia Treatment Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Fibromyalgia Treatment Market Dynamics
Drivers
Rise in the Fibromyalgia
- Various factors affect the growth of the global fibromyalgia treatment market, primarily due to the increasing prevalence of fibromyalgia worldwide. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), about five million people aged 18 and after and have fibromyalgia in the US. It is worth noting that 80 to 90 percent of fibromyalgia patients are mostly women. This sex-specific prevalence highlights the significant impact of fibromyalgia on the female population. Increasing awareness of fibromyalgia and improved diagnostic capabilities are contributing to greater acceptance of the issues worldwide.
Restraints
Use of Non-Pharmaceutical Drugs and Superior Pharmaceuticals
- The limited availability of drugs specifically approved for the treatment of fibromyalgia has now led to only three, despite this increasing reliance on off-label medications and customized antidepressants to address the symptoms of the disease. In June 2019, Pfizer the loss of patent protection for Lyrica, the first drug in the treatment of fibromyalgia, had a significant impact on the drug’s market revenue. While patent protection expired, the generic Lyrica entered the market, increasing competition and subsequent decline in the overall market.
Request Free Customization of this report to help us to meet your business objectives.
Global Fibromyalgia Treatment Market Competitive Landscape
The competitive environment of the global Fibromyalgia Treatment market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor.
Top Player’s Company Profiles
- Pfizer, Inc.
- Eli Lilly and Company
- AbbVie, Inc.
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson Services, Inc
- Sanofi
- GlaxoSmithKline plc.
- Bayer AG
- TONIX Pharmaceuticals Holdings Corp
- Virios Therapeutics, Inc.
- Aptinyx Inc.
- FSD Pharma
Recent Developments
- In December 2020, Tonix Pharmaceuticals disclosed encouraging results from a Phase III study evaluating TNX-102 for the treatment of fibromyalgia. The positive results are a significant milestone for Tonix Pharmaceutical, and demonstrate the potential efficacy of TNX-102 in managing the severe complications associated with fibromyalgia. This achievement demonstrates the company’s determination to enhance treatment options for individuals affected by this chronic pain.
- In June 2020, Teva Pharmaceutical Industries Ltd. will post a $1.2 billion market cap. announced updated data from the AJOVY injection open-label study. The study focused on evaluating the efficacy of AJOVY in both migraine and fibromyalgia. This initiative by Teva Pharmaceutical reflects the pharmaceutical industry’s commitment to finding multiple uses for existing drugs and underscores its ongoing efforts to provide comprehensive therapeutic solutions for conditions such as fibromyalgia.
Global Fibromyalgia Treatment Key Market Trends
- Key players in the global fibromyalgia treatment market are engaged in innovative therapies aimed at sustaining or consolidating their market. The launch and approval of emerging Fibromyalgia treatments will contribute significantly to the market that has developed during the forecast period. Expect an illustrative example of the article galcanezumab, by Eli Lilly & Co.; and developed, with Phase IV clinical trials currently underway from January 2021 -phase to December 2021, primarily for the treatment of fibromyalgia. This expansion of existing indications exemplifies the commitment of large pharmaceutical companies to meet the complex and evolving needs of patients with fibromyalgia.
Global Fibromyalgia Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. Pharmaceutical companies are strengthening their commitment to research and development efforts aimed at developing new treatments for fibromyalgia. This strategic emphasis on enhancing therapeutic modalities is expected to boost the fibromyalgia treatment market in the near future. Increasing investment in research means if fibromyalgia treatment needs are received has not yet addressed its challenges in the pharmaceutical industry have been recognized as aimed at solving, ultimately improving patient outcomes
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.3 billion |
| Market size value in 2031 | USD 2.39 billion |
| Growth Rate | 7.00% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Fibromyalgia Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Fibromyalgia Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Fibromyalgia Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Fibromyalgia Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Fibromyalgia Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Fibromyalgia Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Fibromyalgia Treatment Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
